NHS Framework Agreement, Branded Medicines for London and South of England
Details
- Buyer
- NHS England
- Supplier(s)
41 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Allergan Limited
- Amgen Ltd
- Astra Zeneca UK Limited
- Bayer Ltd
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Celltrion Healthcare United Kingdom Ltd
- Chugai Pharma UK Ltd
- CST Pharma Limited
- Daiichi Sankyo UK Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- Gilead Sciences Ltd, 280 High Holborn
- Ipsen
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Merz
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Profile Pharma Ltd
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- TECHDOW PHARMA ENGLAND LIMITED
- Tetris Pharma Lts
- Teva UK Ltd
- Thornton and Ross
- UCB
- UL Global Pharma
- Vifor Pharma UK Ltd
- Zentiva Pharma UK Ltd
- Value
- £601,111,261,128
- Topic
- Pharmaceutical products
- Published
- 17 September 2021
- Source
- uk:find_a_tender
Tender description
NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab. Lot 1: CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B. CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months Lot 4: CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B. CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 2: CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche. CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months Lot 3: CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A. CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 6: CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab Lot 5: CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche. CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Timeline
- Completed: Award date19 August 2021
- Completed: Award published17 September 2021Current notice
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 401£211.7m
- 307£87.4m
- 292£11.9bn
- 235£2.7bn
- 234£16.4bn
- 221£483.8m
- 218£858.6m
- 194£952.3m
- 117£883.5m
- 94£47.4m
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.